Navigation Links
Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting

investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

Aranesp prescribing information can be accessed by calling 800-772-6436 or by logging on to www.aranesp.com.

Contact

Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aranesp ``145 Study Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:10/12/2008)...tures thin struts designed for more uniform drug ...ass., and WASHINGTON, Oct. 12 /PRNewswire-FirstCal...today announced comprehensive data from,the TAXUS ...ctive,multi-center, single-arm, historically cont...(R) Paclitaxel-Eluting Stent System in a variety o...
(Date:10/10/2008)...phylaxis Treatment with Kogenate FS Reduces the,Ri... with No Pre-Existing,Joint Damage, BERKELEY, Cal...announced today that the U.S. Food and Drug Admini...th Kogenate(R) FS Antihemophilic Factor,(Recombina...nd the risk of,joint damage in patients aged 0-16 ...
(Date:10/9/2008)...gn to Spread Awareness and Bring Hope to Millions,...re-USNewswire/ -- 133 million children,across the ... as natural,disaster, civil war, and disease. SOS ...ld Orphan Week by calling attention to the needs o... Release, go to:, http://www.prnewswire.com/mnr/...
(Date:10/9/2008)... Science Institute, Navigenics, Affymetrix and,Mic...IEGO, Oct. 9 /- A consortium of healt...d forces in a first-of-its-kind,research study to ...esting,on people who choose to receive such screen...ng certain diseases., Sponsored by Scripps Transl...
Breaking Medicine Technology:Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Worlds only captive hairy nosed otter gets new home 3679 1Worlds only captive hairy nosed otter gets new home 3679 2Worlds only captive hairy nosed otter gets new home 3679 3 24100 million supercomputing program boosts Australian medical research capacity 22167 1 24100 million supercomputing program boosts Australian medical research capacity 22167 2Non Surgical Approach Can Treat Lung Cancers 22162 1Non Surgical Approach Can Treat Lung Cancers 22162 2Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference 22157 1
...tients With Improved Potential,to Battle Their Dis...-FirstCall/ --,Arrowhead Research Corporation anno...aries, Insert Therapeutics Inc. and Calando,Pharma...erican,Association for Cancer Research (AACR) Annu... research findings on two,anticancer therapies cur...
...6, 2007 - Introgen Therapeutics,Inc. (NASDAQ:INGN...the weekend in Los Angeles, California at the Annu...Research., Abnormality of the p53 tumor suppressor...ar defects in cancer. ADVEXIN,s,mechanism of actio...nction and the detection of abnormal p53 is a logi...
Other Medicine Technology:Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 2Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 3Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 4Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...ous for being extra conscious in front of the came...g her pins looking far from perfect . The usually...h above and below her knee, making her legs look h...irl was photographed while going for a shoot in ha...
...has sacked her kids' nanny for not turning up on t...hat the babysitter lied to her about visiting her ... the Algarve. The model had to take care of her s...did not turn up, and was delayed for Radio One sho...
... that kids ability to describe past incidences dev...m of researchers led by Yael Orbach at the Nationa...and the University of Cambridge. As part of the s...yzed forensic interviews of 250, 4 to 10-year-old ...
...ss has finally realised the true persona of her ex...e house and getting rid of his belongings, the sup...Slug. According to pals, Moss chose the nickname ...e junkie rockers habit of leaving a trail of nasty...
Other Medicine News:
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: